| Dr Laura Perry, PHARM D | |
|
8 Kocher Dr, Bennington, VT 05201-1923 | |
| (802) 442-8369 | |
| Not Available |
| Full Name | Dr Laura Perry |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 8 Kocher Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518280825 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 033.0003726 (Vermont) | Primary |
| 183500000X | Pharmacist | 050871-1 (New York) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Perry, PHARM D 435 County Route 68, Eagle Bridge, NY 12057-2820 Ph: () - | Dr Laura Perry, PHARM D 8 Kocher Dr, Bennington, VT 05201-1923 Ph: (802) 442-8369 |
News Archive
Pfizer Inc. and Bristol-Myers Squibb Company have announced that they have finalized a definitive agreement for the worldwide collaboration to research, develop and commercialize DGAT-1 inhibitors, a collaboration first announced on April 26, 2007.
Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in their efficacy and safety profiles, according to new research by the University of Leicester.
Identifying people who are at risk for Type 2 diabetes should become "a focus for everybody," say new UK guidelines.
A court case has revealed that the insurer Fortis, now called Assurant Health, automatically targeted customers diagnosed with HIV for fraud investigations geared toward finding reasons to revoke their coverage, Reuters reports. After a computer algorithm initiated the investigations, "their insurance policies often were canceled on erroneous information, the flimsiest of evidence, or for no good reason at all, according to the court documents and interviews with state and federal investigators."
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study. Ninety-two percent of the 39 children receiving bioengineered T cells had no evidence of cancer at one month after treatment, with this complete response persisting in some cases for more than two years.
› Verified 9 days ago
Tyler Brian Walsh, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Kocher Dr, Bennington, VT 05201 Phone: 802-442-8369 | |
Dr. Ann Snyder Franklin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 140 Hospital Dr Ste 116, Bennington, VT 05201 Phone: 802-447-4272 | |
Dr. Gregory Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Northside Dr, Bennington, VT 05201 Phone: 802-442-6822 Fax: 802-442-8356 | |
Laurie Louise Lincoln, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-447-5372 Fax: 802-447-5373 | |
Kerri L Ryan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8 Kocher Dr, Bennington, VT 05201 Phone: 802-442-8369 Fax: 802-447-3174 | |
Dr. Kenneth Breaux Segreto, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 141 Hannaford Sq # 2, Bennington, VT 05201 Phone: 802-442-3642 Fax: 802-442-3065 | |
Dr. Jennifer Anderson, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 North St, Bennington, VT 05201 Phone: 802-442-5602 |